CAEDO ONCOLOGY AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−265k kr).
- Nylig endring 2026-07-21 Aksjekapital registrert 2026-07-21.
CAEDO ONCOLOGY AS is registered as a limited company in Oslo, Oslo with organisation number 926135082. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 2020. Registered share capital is NOK 214,000, divided into 214366 shares. The company's stated purpose is: “Utvikle, markedsføre og selge medisinske produkter og utstyr samt det som står i forbindelse med dette.”. The most recent filed accounts, for the 2025 financial year, show NOK 1.8m in revenue and NOK −265,000 in operating profit.
Key figures · 2025
Financial health · 2025
Who owns CAEDO ONCOLOGY AS?
CAEDO ONCOLOGY AS has 13 registered shareholders:
- SARSIA SEED FOND II AS 39.8%
- SATURN INVEST AS 21.4%
- R OG L AS 12.0%
- K OG K AS 10.5%
- JAC MOE AS 4.5%
- ERM INVEST AS 3.5%
- STENSHAGEN INVEST AS 3.3%
- FARVATN VENTURE AS 1.7%
- METTE RAGNHILD KLØVSTAD OLAFSEN 1.3%
- AAMESO AS 1.1%
- INITIA AS 0.5%
- TORBJØRN LEIV ØYE 0.2%
- THOMAS MEUM ANDERSEN 0.2%
Frequently asked questions about CAEDO ONCOLOGY AS
Who owns CAEDO ONCOLOGY AS?
SARSIA SEED FOND II AS is the largest registered owner, with 39.8%.
What is the revenue of CAEDO ONCOLOGY AS?
CAEDO ONCOLOGY AS had revenue of NOK 1.8m in 2025.
Who is the general manager of CAEDO ONCOLOGY AS?
Kjetil Hestdal is registered as general manager of CAEDO ONCOLOGY AS.
Where is CAEDO ONCOLOGY AS based?
CAEDO ONCOLOGY AS has its business address in Oslo.
Property
292 companies are registered at this address.
The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.